RJFSA
QNRX

Raymond James Financial Services Advisors’s Quoin Pharmaceuticals QNRX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$12.4K Buy
+718
New +$15.1K ﹤0.01% 3416
2019
Q3 		– Hold
0
– -$6K – 2917
2019
Q2 		– Hold
0
– – – 2830
2019
Q1 		– Hold
0
– – – 2770
2018
Q4 		– Hold
0
– – – 2508

Other funds holding QNRX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Raymond James Financial Services Advisors's QNRX Position: Q3 2024 in Review

Raymond James Financial Services Advisors opened a new position in Quoin Pharmaceuticals (QNRX) in Q3 2024: 718 shares worth $12.4K. The stake represents ﹤0.01% of the portfolio and ranks #3416 among its holdings.

7 funds tracked by Wall St. Rank hold QNRX as of Q3 2024.

  • Raymond James Financial Services Advisors held 718 shares of Quoin Pharmaceuticals worth $12.4K as of Q3 2024.
  • Quoin Pharmaceuticals was a new Raymond James Financial Services Advisors position in Q3 2024.
  • Quoin Pharmaceuticals made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3416 holding.
  • 7 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.